共 50 条
- [22] CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01): : 89 - 90
- [24] Plasmapheresis combined with rituximab for refractory idiopathic membranous nephropathy International Urology and Nephrology, 2014, 46 : 847 - 848
- [25] Case report: Successful treatment of refractory membranous nephropathy with telitacicept FRONTIERS IN IMMUNOLOGY, 2023, 14
- [26] Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2021, 11 (02): : 116 - 123
- [27] Is low-dose ciclosporin an effective treatment for membranous nephropathy with nephrotic syndrome? NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (04): : 190 - 191
- [28] Is low-dose ciclosporin an effective treatment for membranous nephropathy with nephrotic syndrome? Nature Clinical Practice Nephrology, 2007, 3 : 190 - 191